MicroRNAs and noncoding RNAs in hematological malignancies: molecular, clinical and therapeutic implications.
about
Investigating the targets of MIR-15a and MIR-16-1 in patients with chronic lymphocytic leukemia (CLL)EVI1 controls proliferation in acute myeloid leukaemia through modulation of miR-1-2Silencing of microRNA-155 in mice during acute inflammatory response leads to derepression of c/ebp Beta and down-regulation of G-CSFThe Potential of Vitamin D-Regulated Intracellular Signaling Pathways as Targets for Myeloid Leukemia TherapyTranscribed ultraconserved region in human cancersMicroRNA 132 regulates nutritional stress-induced chemokine production through repression of SirT1Epigenetic changes induced by air toxics: formaldehyde exposure alters miRNA expression profiles in human lung cellsA large scale expression study associates uc.283-plus lncRNA with pluripotent stem cells and human gliomaCorrelation of microRNA levels during hypoxia with predicted target mRNAs through genome-wide microarray analysis.MicroRNAs expression signatures are associated with lineage and survival in acute leukemias.Vitamin D3-driven signals for myeloid cell differentiation--implications for differentiation therapyDevelopmental transcriptome analysis of human erythropoiesis.The tumour-suppressive miR-29a/b1 cluster is regulated by CEBPA and blocked in human AML.Leukaemogenesis: more than mutant genesMicroRNA-223 reversibly regulates erythroid and megakaryocytic differentiation of K562 cells.The levels of hypoxia-regulated microRNAs in plasma of pregnant women with fetal growth restriction.Opposite Prognostic Significance of Cellular and Serum Circulating MicroRNA-150 in Patients with Chronic Lymphocytic LeukemiamiR-203 and miR-221 regulate SOCS1 and SOCS3 in essential thrombocythemiaAssociation of a microRNA/TP53 feedback circuitry with pathogenesis and outcome of B-cell chronic lymphocytic leukemia.Epigenetics of acute lymphocytic leukemia.miR-150 Suppresses the Proliferation and Tumorigenicity of Leukemia Stem Cells by Targeting the Nanog Signaling Pathway.The Role of miRNA in Haematological Malignancy.Inhibition of MicroRNA miR-92a Inhibits Cell Proliferation in Human Acute Promyelocytic Leukemia.Nuclear microRNAs in normal hemopoiesis and cancerA tumor-promoting mechanism mediated by retrotransposon-encoded reverse transcriptase is active in human transformed cell lines.c-Myc suppresses miR-451⊣YWTAZ/AKT axis via recruiting HDAC3 in acute myeloid leukemia.Upregulation of miR-99a is associated with poor prognosis of acute myeloid leukemia and promotes myeloid leukemia cell expansion.Marek's disease virus-encoded microRNAs: genomics, expression and function.Role of microRNAs in lymphoid biology and disease.Deregulated microRNAs in multiple myeloma.MicroRNAs in hematological malignancies: a novel approach to targeted therapy.Differentiation therapy of acute myeloid leukemia.microRNAs: role in leukemia and their computational perspective.Acute myeloid leukemia with translocation (8;16)(p11;p13) and MYST3-CREBBP rearrangement harbors a distinctive microRNA signature targeting RET proto-oncogene.Involvement of MicroRNA in T-Cell Differentiation and MalignancyDegradation of miR-21 induces apoptosis and inhibits cell proliferation in human hepatocellular carcinoma.Current Status and Perspectives Regarding LNA-Anti-miR Oligonucleotides and microRNA miR-21 Inhibitors as a Potential Therapeutic Option in Treatment of Colorectal Cancer.Inhibition of microRNA miR-92a induces apoptosis and inhibits cell proliferation in human acute promyelocytic leukemia through modulation of p63 expression.miR-181b modulates glioma cell sensitivity to temozolomide by targeting MEK1.Targeting of the signal transducer Smo links microRNA-326 to the oncogenic Hedgehog pathway in CD34+ CML stem/progenitor cells.
P2860
Q21562355-3E419497-A994-44EE-9A5D-04E1C1B61C4AQ24620267-5A916F30-D496-473E-82CE-D42D30461210Q24653834-D2FD0F3D-B6EB-41DC-83F8-C2BF875E7461Q26799596-6C9D76AB-E285-4C4C-AD82-2BD59E3315CEQ26996430-345C94E3-AB4D-4789-A2A9-E454F68C1C88Q28261153-01056C0A-6FBC-4FAF-9CAE-C919299D2D22Q28388059-3601A545-C5AD-467B-A435-5995B64C6455Q28654361-29B30E73-708C-42ED-8385-6A6639BBCA5EQ30860022-FB5AABF3-A3EE-41F3-8A3C-D790688F98B1Q33691247-7983A4B4-BCAA-411F-9A5F-844E6070044BQ33759350-93639892-0EC2-46A9-AC72-F3845BF003B1Q33991726-2B2F4218-DD6B-481A-B102-421913482BD5Q34005915-76E90B34-3ED0-42CB-A7E9-4A7752556995Q34275371-CF3432A2-2FAA-478B-A0F9-79D0C0ABF724Q34883097-2A1F6C71-6BF0-4BE7-B55C-C36312BD8A0DQ35482938-23AECE52-02F1-4FA1-9720-CC856BF77346Q35707206-6F81EF2D-6CE4-45E7-ADFC-AED3E8544DEEQ36754808-6C58B5F6-D898-4B77-B6F2-BACDC36C54F2Q36948708-B137CB08-7E57-49FA-A499-929D1CBFFE76Q37355967-3FDE3EA2-2116-4D78-8DAA-1C88BAC825FAQ37421084-76C648EB-D984-441E-A1D3-0A8A95EA241EQ37422388-EB5C0459-B858-4C42-B2DF-E28B3C6B20ADQ37426427-243073D8-B07E-44E6-AE88-D77440425815Q37565996-5AFE5A9E-05DF-4A61-AB36-B9BDE367B8A1Q37589125-C64A29F0-3EC8-4D68-9740-2BDC4914A699Q37718379-CD08258B-2A88-4BD6-B2AF-E8D321492A1FQ37718496-01FB945F-4AD6-463E-BF26-E6C3F7983534Q37800855-84B77B83-C0E7-4D61-AE8E-417CC3DCDE1AQ37868870-9EBF7114-4BA1-4AC8-ADCE-7CC93A1D6703Q37916411-018C6D98-589F-4D1E-AB42-793B6D528D49Q38015971-D1DE4BBD-A7E2-4855-AD53-C5F43893E8EEQ38161360-947F14D8-B797-441E-ADFA-BC870F8CEEA5Q38240767-0320F5CC-91F4-45C9-9816-57EFC49158F1Q38321235-A1713D84-33CD-4DBE-8030-74DFEA45C0B0Q38388753-36382BBE-DF8A-494D-901C-23CA3CEE926DQ38830997-AD9C567C-0467-4529-9FC9-76BECBBDD1F1Q38841033-35521318-D7C7-4063-B78C-C588E1FD3B94Q39028638-3B880465-D6C4-4083-891D-7A2234B3A825Q39156112-858E37C0-5981-46D2-A821-F4AA56979F8DQ39206405-1EA5CB87-437A-44DC-B7D2-D8582E361336
P2860
MicroRNAs and noncoding RNAs in hematological malignancies: molecular, clinical and therapeutic implications.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 March 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
MicroRNAs and noncoding RNAs i ...... and therapeutic implications.
@en
MicroRNAs and noncoding RNAs i ...... and therapeutic implications.
@nl
type
label
MicroRNAs and noncoding RNAs i ...... and therapeutic implications.
@en
MicroRNAs and noncoding RNAs i ...... and therapeutic implications.
@nl
prefLabel
MicroRNAs and noncoding RNAs i ...... and therapeutic implications.
@en
MicroRNAs and noncoding RNAs i ...... and therapeutic implications.
@nl
P2093
P2860
P356
P1433
P1476
MicroRNAs and noncoding RNAs i ...... and therapeutic implications.
@en
P2093
G Garcia-Manero
H M Kantarjian
M Andreeff
P2860
P2888
P304
P356
10.1038/LEU.2008.30
P577
2008-03-06T00:00:00Z